Figure 4 demonstrates that the T2DM mice induced via a HFD and STZ showed weight loss, a significant increase in blood glucose, and increased food intake. All of the mice in the TAC and TAC/MSC groups had weight gain and decreased food consumption and blood glucose after 4 weeks of administration. We speculated that this change might be related to the improvement in insulin sensitivity (Figure 5). The gene discussed is INS; the disease is type 2 diabetes mellitus.